name: MiniMed Mio Advance Infusion Set 9MM-23 inch


name: MiniMed Mio Advance Infusion Set 9MM-43 inch


name: Nuvagel Silicone Gel Scar Dressing Sheets


name: Milk Protein/Soy Protein Oral Suspension [BOOST GLUCOSE CONTROL]


name: Milk Protein/Soy Protein Oral Suspension [RESOURCE 2.0]


name: Milk Protein/Soy Protein Oral Suspension [TWOCAL HN]


name: Petrolatum/Zinc Oxide 87.3%-8.8% Topical application Ointment


name: {42 (infigratinib 25 MG Oral Capsule [Truseltiq]) } Pack [Truseltiq 50 MG Daily Dose Carton]


name: {63 (infigratinib 25 MG Oral Capsule) } Pack


name: {63 (infigratinib 25 MG Oral Capsule [Truseltiq]) } Pack [Truseltiq 75 MG Daily Dose Carton]


name: {2 (thyrotropin alfa 0.9 MG Injection) } Pack


name: {21 (infigratinib 100 MG Oral Capsule) } Pack


name: AVOBENZONE 2.8 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL CREAM [Defense Refresh (Re)Setting Mist SPF 40]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 7 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL CREAM [StriVectin multi-action Super-C SPF 30]


name: OCTINOXATE 7.5 g in 100 mL / Zinc Oxide 7.0 g in 100 mL / Titanium Dioxide 4.19 g in 100 mL TOPICAL CREAM [MISSHA M PERFECT COVER BB NO.13 BRIGHT BEIGE]


name: {42 (infigratinib 25 MG Oral Capsule) } Pack


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 8 g in 100 mL / OCTOCRYLENE 4 g in 100 mL TOPICAL CREAM [Unseen Sunscreen SPF 40]


name: OCTOCRYLENE 7.5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL / HOMOSALATE 10 g in 100 mL TOPICAL CREAM [Play Everyday SPF 50 with Sunflower Extract]


name: OXYBENZONE 6 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 13 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL LOTION [Coppertone Kids Sunscreen SPF 70]


name: TITANIUM DIOXIDE 3.5 g in 100 mL / ZINC OXIDE 9.5 g in 100 mL TOPICAL CREAM [Eezysun Sunscreen SPF 50 with Aloe Vera, Marine Friendly]


name: ZINC OXIDE 12 g in 100 g TOPICAL CREAM [Vanicream Sunscreen Sport Broad Spectrum SPF 35]


name: Always Foundation Makeup Broad Spectrum SPF 15 Deluxe Sample Kit KIT


name: BENZOCAINE 4.5 g in 60 mL TOPICAL SPRAY [Trojan Extended Pleasure]


name: HOMOSALATE 10 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL STICK [Play Lip Shield with Mint Broad Spectrum SPF 30]


name: HOMOSALATE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL OIL [Glow Oil Sunscreen SPF 50]


name: ZINC OXIDE 200 mg in 1 mL / TITANIUM DIOXIDE 88.2 mg in 1 mL TOPICAL CREAM [UV PROTECT FACE SPF 50]


name: ZINC OXIDE 35 mg in 1 g TOPICAL STICK [Broad Spectrum SPF 15 Coconut Lip Balm]


name: SENNOSIDES 20 kg in 20 kg POWDER [Calcium Sennosides 60%]


name: ZINC OXIDE 182 mg in 1 mL TOPICAL CREAM [Usana Celavive Daily Mineral Protective Cream Moisturizer with Sunscreen SPF 30]


name: TETRACYCLINE HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 20 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL / TITANIUM DIOXIDE 30 mg in 1 mL / ZINC OXIDE 30 mg in 1 mL TOPICAL LIQUID [ORIGINS GINZING ENERGY-BOOSTING TINTED MOISTURIZER BROAD SPECTRUM SPF 40]


name: OCTOCRYLENE 60 mg in 1 mL / OCTINOXATE 49.95 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OXYBENZONE 30 mg in 1 mL TOPICAL CREAM [Bali Body BB Cream SPF 15 Natural]


name: ZINC OXIDE 23.814 g in 113.4 g TOPICAL EMULSION [Mineral Sunscreen]


name: ZINC OXIDE 9.919 g in 61 g TOPICAL EMULSION [Sunscreen Flawless Skin fluid tinted]


name: HOMOSALATE 2.53 g in 50 mL / OCTOCRYLENE 2.53 g in 50 mL / OCTISALATE 2.53 g in 50 mL / AVOBENZONE 1.012 g in 50 mL TOPICAL EMULSION [SHISEIDO ESSENTIAL ENERGY HYDRATING DAY]


name: OCTINOXATE 1.07 g in 21 mL / TITANIUM DIOXIDE 0.3 g in 21 mL TOPICAL EMULSION [cle de peau BEAUTE RADIANT FOUNDATION N B100]


name: TITANIUM DIOXIDE 1.77 g in 40 mL / OCTINOXATE 1.71 g in 40 mL / ENSULIZOLE 0.428 g in 40 mL TOPICAL EMULSION [SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER]


name: TITANIUM DIOXIDE 2 g in 100 g / ZINC OXIDE 18.4 g in 100 g TOPICAL CREAM [NELLY DEVUYST BIOSOLAR COLORLIFT 1 TINTED SUNSCREEN 30 mL SPF30]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [in2itiv SPF30 Sunscreen]


name: TITANIUM DIOXIDE 88.5 mg in 1 mL / ZINC OXIDE 19.1 mg in 1 mL TOPICAL LOTION [Derm Institute Daily Defense Protection Sunscreen Broad Spectrum SPF50]


name: ZINC OXIDE 147 mg in 1 g / TITANIUM DIOXIDE 43 mg in 1 g TOPICAL SPRAY [MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50]


name: zinc oxide 49.5 mg in 1 g TOPICAL CREAM [BrightenUp Illuminating with Mineral Broad Spectrum SPF 15 Sunscreen]


name: ZINC OXIDE 189 mg in 1 mL TOPICAL CREAM [Eclipse Sheer Mineral Sunscreen Broad Spectrum SPF 30]


name: LACTOBACILLUS ACIDOPHILUS 16000000000 [CFU] / BIFIDOBACTERIUM ANIMALIS LACTIS 15000000000 [CFU] ORAL CAPSULE [Probitran]


name: Titanium Dioxide 45 mg in 1 g / Zinc Oxide 128 mg in 1 g TOPICAL CREAM [Obagi Medical Physical Defense Broad Spectrum Mineral Sunscreen SPF 40 by SUZANOBAGIMD]


name: Titanium Dioxide 58 mg in 1 g / Zinc Oxide 144 mg in 1 g TOPICAL CREAM [Obagi Medical Physical Defense Broad Spectrum Mineral Sunscreen SPF 50 by SUZANOBAGIMD]


name: ZINC OXIDE 21 g in 100 g TOPICAL CREAM [LATHER- DAILY DEFENSE MINERAL SPF 50]


name: ARGININE 1 kg in 1 kg NOT APPLICABLE POWDER


name: AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL CREAM [Glowscreen SPF 40]


name: AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 7.5 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL LOTION [Play Everyday SPF 50 with Sunflower Extract]


name: Avobenzone 25 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 80 mg in 1 mL TOPICAL LOTION [VACATION CLASSIC BROAD SPECTRUM SPF 30 SUNSCREEN]


name: HOMOSALATE 8 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL CREAM [Superscreen Daily Moisturizer SPF 40]


name: Madecassoside 0.26 g in 100 g / Asiaticoside 0.012 g in 100 g TOPICAL CREAM [Dr.Different CICA Metal]


name: METHOCARBAMOL 1 kg in 1 kg NOT APPLICABLE POWDER


name: Avobenzone 30 mg in 1 g / Homosalate 100 mg in 1 g / Octisalate 50 mg in 1 g TOPICAL LIPSTICK [SUNPROOF INTENSIVE LIP BALM Broad Spectrum SPF 24 Sunscreen FRESH MINT]


name: Avobenzone 30 mg in 1 g / Homosalate 100 mg in 1 g / Octisalate 50 mg in 1 g TOPICAL LIPSTICK [SUNPROOF INTENSIVE LIP BALM Broad Spectrum SPF 24 Sunscreen SWEET TANGERINE]


name: ZINC OXIDE 66.6 mg in 1 mL / TITANIUM DIOXIDE 99.9 mg in 1 mL TOPICAL LOTION [Blue Lizard Sheer SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Sun bum Daily Sunscreen Moisturizer SPF 30]


name: HOMOSALATE 2.02 g in 15 g / OCTOCRYLENE 1.35 g in 15 g / OCTISALATE 0.67 g in 15 g / AVOBENZONE 0.40 g in 15 g TOPICAL STICK [ATOMY SUN]


name: OCTOCRYLENE 60 mg in 1 mL / OCTINOXATE 49.95 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OXYBENZONE 30 mg in 1 mL TOPICAL CREAM [Bali Body BB Cream SPF 15 Tan]


name: TITANIUM DIOXIDE 0.7 g in 100 mL / ZINC OXIDE 17 g in 100 mL TOPICAL CREAM [Mattescreen SPF 40]


name: TITANIUM DIOXIDE 34 mg in 1 g / ZINC OXIDE 160 mg in 1 g TOPICAL LIQUID [Sun Bum Mineral Sunscreen SPF 50]


name: Titanium Dioxide 1.41 g in 16 g TOPICAL STICK [ATOMY DERMA CALMING SUN]


name: Adenosine 0.04 g in 100 mL TOPICAL PATCH [ARILAC Anti Wrinkle Mask Sheet Pack]


name: Niacinamide 2.0 g in 100 mL TOPICAL PATCH [ARILAC Brightening Mask Sheet Pack]


name: ZINC OXIDE 17.5 g in 100 mL TOPICAL CREAM [Mineral Sheerscreen SPF 30]


name: ZINC OXIDE 25 g in 100 g TOPICAL OINTMENT [All Good]


name: ZINC OXIDE 5.625 g in 30 mL TOPICAL LOTION


name: VITAMIN A PALMITATE .225 mg in 1 mL / SODIUM ASCORBATE 35 mg in 1 mL / CHOLECALCIFEROL .01 mg in 1 mL ORAL SOLUTION [Tri-Vite Pediatric Oral Solution]


name: VITAMIN A PALMITATE .25 mg in 1 mL / SODIUM ASCORBATE 50 mg in 1 mL / CHOLECALCIFEROL .01 mg in 1 mL / ALPHA-TOCOPHEROL ACETATE 5 mg in 1 mL / THIAMINE HYDROCHLORIDE .3 mg in 1 mL / RIBOFLAVIN 5'-PHOSPHATE SODIUM .4 mg in 1 mL / NIACINAMIDE 4 mg in 1 mL / PYRIDOXINE HYDROCHLORIDE .3 mg in 1 mL / CYANOCOBALAMIN .5 mg in 1 mL ORAL SOLUTION [Poly-Vite Pediatric Oral Solution]


name: VITAMIN A PALMITATE .25 mg in 1 mL / SODIUM ASCORBATE 50 mg in 1 mL / CHOLECALCIFEROL .01 mg in 1 mL / ALPHA-TOCOPHEROL ACETATE 5 mg in 1 mL / THIAMINE HYDROCHLORIDE .3 mg in 1 mL / RIBOFLAVIN 5'-PHOSPHATE SODIUM .4 mg in 1 mL / NIACINAMIDE 4 mg in 1 mL / PYRIDOXINE HYDROCHLORIDE .3 mg in 1 mL / CYANOCOBALAMIN .5 mg in 1 mL / FERROUS SULFATE 11 mg in 1 mL ORAL SOLUTION [Poly-Vite/Iron Oral Solution]


name: BEZAFIBRATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: RESORCINOL 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Okay Mens Aluminium Free Deodorant Stick]


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / HOMOSALATE 10 g in 100 mL TOPICAL LOTION [GoodSense SPF 30 Sunscreen]


name: ZINC OXIDE 17.4 g in 100 mL / TITANIUM DIOXIDE 1.3 g in 100 mL TOPICAL CREAM [Mineral Mattescreen SPF 40]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine for Women Charcoal Antiperspirant / Deodorant]


name: AVOBENZONE 2.5 g in 100 g / OCTOCRYLENE 7 g in 100 g TOPICAL STICK [Nivea Smoothness Lip Care]


name: NIACINAMIDE 0.6 g in 30 mL / ADENOSINE 0.012 g in 30 mL TOPICAL LIQUID [AROCELL MILKY DROP FINISH AMPOULE]


name: ZINC OXIDE 8.25 g in 44 mL TOPICAL LOTION


name: AVOBENZONE 20 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 20 mg in 1 mL / OCTOCRYLENE 10 mg in 1 mL TOPICAL CREAM [Sun Bum Hand Cream SPF15]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Sun Bum Daily Mineral Sunscreen Moisturizer SPF30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Sun Bum Daily Sunscreen Face Mist SPF30]


name: ZINC OXIDE 120 mg in 1 mL TOPICAL LOTION [Glytone Age Defense UV Mineral Sunscreen Serum Broad Spectrum SPF 50 PLUS]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Tinted Mineral Sunscreen Broad Spectrum SPF 30]


name: CAPROLACTONE 1 kg in 1 kg NOT APPLICABLE LIQUID


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 158 mg in 1 g TOPICAL STICK [Speed Stick Cool Clean]


name: AVOBENZONE 1 g in 100 g / OCTOCRYLENE 3 g in 100 g TOPICAL OIL [Hawaiin Tropic Island Tanning SPF 6]


name: TITANIUM DIOXIDE 64 mg in 1 mL TOPICAL EMULSION [VITALUMIERE AQUA ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 10 BEIGE]


name: AVOBENZONE 18 mg in 1 g / OCTISALATE 30 mg in 1 g / OCTOCRYLENE 60 mg in 1 g / HOMOSALATE 90 mg in 1 g TOPICAL AEROSOL, SPRAY [Bondi Sands Sport SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [BONDI SANDS SPORT SPF 30 SUNSCREEN]


name: ASCORBIC ACID 250 mg in 1 g / CHOLECALCIFEROL 30 ug in 1 g / .ALPHA.-TOCOPHEROL 20 mg in 1 g / NIACINAMIDE 16 mg in 1 g / BIOTIN 50 ug in 1 g / ZINC SULFATE 10 mg in 1 g / SELENIUM 50 ug in 1 g / MARINE COLLAGEN, SOLUBLE 5000 mg in 1 g / HYALURONIC ACID 50 mg in 1 g / ALOE VERA LEAF 100 mg in 1 g / OPHIOCORDYCEPS SINENSIS 100 mg in 1 g / ELASTIN BOVINE 10 mg in 1 g / SOYBEAN 100 mg in 1 g / RICE BRAN 100 mg in 1 g / MARITIME PINE 60 mg in 1 g ORAL POWDER [JBA Collagen-B]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL SOLUTION [INTIMALE Maximum Strength Delay]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL SOLUTION [POWERECT Max Power Male Delay]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL SOLUTION [SKINS DELAY Maximum Strength Lidocaine]


name: ADENOSINE 0.003 g in 9 g TOPICAL STICK [BVBLAB SQUALAN SERUM STI CK 70]


name: GLUCONOLACTONE 0.029 mg in 1.4 mg / EPIGALLOCATECHIN GALLATYL GLUCOSIDE 0.0007 mg in 1.4 mg / Madecassoside 0.00001 mg in 1.4 mg TOPICAL PATCH [DR.PLINUS ZERO TROUBLE]


name: HYALURONATE SODIUM 0.21 g in 0.3 g / Niacinamide 0.007 g in 0.3 g / Adenosine 0.0002 g in 0.3 g TOPICAL PATCH [DR.PLINUS FILLINCELL MULTI]


name: NIACINAMIDE 2.6 g in 130 mL / ADENOSINE 0.05 g in 130 mL TOPICAL CREAM [BVBLAB Cellular Body Firming]


name: LAURYL ALCOHOL 1 mL in 1 mL NOT APPLICABLE LIQUID


name: STANNOUS 2-ETHYLHEXANOATE 1 g in 1 g NOT APPLICABLE LIQUID


name: Titanium Dioxide 40 mg in 1 g / Zinc Oxide 55 mg in 1 g TOPICAL STICK [CoTZ Lip Balm]


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [CoTZ Face Prime and Protect SPF 40 (Tinted)]


name: ZINC OXIDE 25 g in 100 g TOPICAL POWDER [PerfecTint Powder SPF 40 All Shades]


name: Zinc Oxide 270 mg in 1 mL TOPICAL LIQUID [Mineral Prismatic Luminizing Shield SPF 35]


name: {21 (infigratinib 100 MG Oral Capsule [Truseltiq]) / 21 (infigratinib 25 MG Oral Capsule [Truseltiq]) } Pack [Truseltiq 125 MG Daily Dose Carton]


name: {56 (elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack


name: {1 (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet) / 1 (acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet) } Pack


name: {21 (infigratinib 100 MG Oral Capsule) / 21 (infigratinib 25 MG Oral Capsule) } Pack


name: {2 (thyrotropin alfa 0.9 MG Injection [Thyrogen]) } Pack [Thyrogen Kit (0.9 MG Vial)]


name: pen needle, diabetic 31 gauge X 15/64" MISCELL NEEDLE, DISPOSABLE


name: lactose-reduced food 0.06 gram-0.8 kcal/mL ORAL LIQUID (ML)


name: amino acids/protein hydrolysate 16 gram-100 kcal/30 mL ORAL LIQUID (ML)


name: amino acids/protein hydrolysate 16 gram-100 kcal/30 mL ORAL LIQUID IN METERED-DOSE PUMP


name: whey protein concentrate 5 gram-26 kcal ORAL POWDER (GRAM)


name: diluent for artesunate (sodium phosphate) INTRAVEN VIAL (ML)


name: diluent for melphalan (sodium citrate) 10 mL INTRAVEN VIAL (ML)


name: diluent for naltrexone microspheres (carboxymethylcellulose) INTRAMUSC VIAL (ML)


name: amino acids/protein hydrolysate 16 gram-100 kcal/30 mL ORAL LIQUID IN PACKET (ML)


name: B6/mfolate/B12/acetylcarnitine/acetylcysteine/ginko/herbs 5 mg-100 mcg DFE-100 mcg-250 mg-100 mg-60 mg ORAL CAPSULE


name: eyelid cleanser combination no.11 TOPICAL FOAM (ML)


name: suppository base no.246 MISCELL FLAKES (GRAM)


name: nutritional therapy, metabolic disorder, methionine-free 38.2 gram-376 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional tx, ketogenic,whey 3.2 gram-149 kcal/100 mL ORAL LIQUID (ML)


name: nutritional tx, ketogenic,whey 3.4 gram-150 kcal/100 mL ORAL LIQUID (ML)


name: emollient combination no.116 TOPICAL LOTION (GRAM)


name: chemical allergens TOPICAL ADHESIVE PATCH, MEDICATED


name: diluent for artesunate (sodium phosphate)


name: diluent for naltrexone microsphere (carboxymethyl)


name: ADAPTER,FEEDING,16FR ENFIT CARDINAL #8884751622E


name: BAG,AEROSOL DRAINAGE WITH TRACH ELBOW AIRLIFE #55001560


name: BANDAGE KIT,COMPRESSION COFLEX TLC CALAMINE STANDARD


name: CATHERIZATION SET,URETHRAL 14FR CURITY #3143


name: CATHETER,FOLEY 2-WAY 20FR 5ML COVIDIEN #681621


name: CATHETER,FOLEY SILICONE 16FR 30ML MEDLINE #DYND11532


name: CATHETER,INTERMITTENT 10FR LOFRIC PRIMO #4111040


name: CATHETER,INTERMITTENT COUDE 12FR COLOPLAST #20022


name: CATHETER,INTERMITTENT COUDE 12FR CURE #HM12C


name: CATHETER,INTERMITTENT,MAGIC3 12FR BARD #53812G


name: CATHETER,SUCTION,14FR KIT CARDINAL HEALTH #ZRSCK14


name: DRESSING,AMD FOAM DISC 1IN CARDINAL #55511AMD


name: DRESSING,TEGADERM CHG 4IN X 4.75IN #1658


name: IRRIGATION KIT W/PISTON SYRINGE CARDINAL #ZRPIT


name: LEG BAG HOLDER,FABRIC,LARGE CAREFIX #120501


name: RESERVOIR,MEDICATION CASSETTE CADD #21-7302-24


name: SET,INFUSION SUBCUTANEOUS ALLMED #MCQU3606-SS


name: SUCTION TUBE ATTACHMENT DEVICE CARDINAL HEALTH #K61


name: microtubule sliding involved in mitotic spindle elongation


name: coflocculation via lectin-mannose interaction


name: coflocculation via protein-carbohydrate interaction


name: activation of MAPK activity involved in osmosensory signaling pathway


name: activation of MAPKK activity during osmolarity sensing


name: activation of MAPKK activity involved in osmosensory signaling pathway


name: activation of MAPKKK activity during osmolarity sensing


name: activation of MAPKKK activity involved in osmosensory signaling pathway


name: inactivation of MAPK activity involved in osmosensory signaling pathway


name: osmolarity sensing, activation of MAP kinase kinase activity


name: osmolarity sensing, activation of MAP kinase kinase kinase activity


name: osmolarity sensing, activation of MAPK activity


name: osmolarity sensing, activation of MAPKK activity


name: osmolarity sensing, activation of MAPKKK activity


name: termination of MAPK activity during osmolarity sensing


name: regulation of cytokine biosynthetic process


name: inhibition of cytokine biosynthetic process


name: negative regulation of cytokine biosynthetic process


name: negative regulation of cytokine secretion


name: positive regulation of cytokine biosynthetic process


name: positive regulation of cytokine secretion


name: cytokine biosynthetic process involved in immune response


name: cytokine secretion during immune response


name: cytokine secretion involved in immune response


name: antibody secretion during immune response


name: immunoglobulin biosynthetic process involved in immune response


name: immunoglobulin secretion involved in immune response


name: immune response in mucosal-associated lymphoid tissue


name: platelet activating factor secretion involved in acute inflammatory response


name: platelet activating factor secretion involved in inflammatory response


name: regulation of immunoglobulin biosynthetic process


name: negative regulation of immunoglobulin biosynthetic process


name: negative regulation of immunoglobulin secretion


name: positive regulation of immunoglobulin biosynthetic process


name: positive regulation of immunoglobulin secretion


name: regulation of cytokine biosynthetic process involved in immune response


name: regulation of cytokine secretion involved in immune response


name: negative regulation of cytokine biosynthetic process involved in immune response


name: negative regulation of cytokine secretion involved in immune response


name: positive regulation of cytokine biosynthetic process involved in immune response


name: positive regulation of cytokine secretion involved in immune response


name: defense response signaling pathway, resistance gene-dependent


name: magnesium-dependent protein serine/threonine phosphatase activity


name: ARF guanyl-nucleotide exchange factor activity


name: cAMP-dependent guanyl-nucleotide exchange factor activity


name: Rab guanyl-nucleotide exchange factor activity


name: Rac guanyl-nucleotide exchange factor activity


name: Ral guanyl-nucleotide exchange factor activity


name: Ran guanyl-nucleotide exchange factor activity


name: Rap guanyl-nucleotide exchange factor activity


name: Ras guanyl-nucleotide exchange factor activity


name: Rho guanyl-nucleotide exchange factor activity


name: Sar guanyl-nucleotide exchange factor activity


name: signal transduction involved in mitotic cell cycle G1/S checkpoint


name: signal transduction involved in mitotic G2/M transition checkpoint


name: signal transduction involved in Dma1-dependent checkpoint


name: signal transduction involved in SAC-independent checkpoint


name: signaling cascade involved in Dma1-dependent checkpoint


name: signaling cascade involved in SAC-independent checkpoint


name: signaling pathway involved in Dma1-dependent checkpoint


name: signaling pathway involved in SAC-independent checkpoint


name: down regulation of signal transduction involved in mitotic G2 DNA damage checkpoint


name: down regulation of signal transduction involved in mitotic G2/M transition DNA damage checkpoint


name: inhibition of signal transduction involved in mitotic G2 DNA damage checkpoint


name: negative regulation of signal transduction involved in mitotic G2 DNA damage checkpoint


name: negative regulation of signal transduction involved in mitotic G2/M transition DNA damage checkpoint


name: positive regulation of signal transduction involved in mitotic G2 DNA damage checkpoint


name: positive regulation of signal transduction involved in mitotic G2/M transition DNA damage checkpoint


name: regulation of signal transduction involved in mitotic G2 DNA damage checkpoint


name: regulation of signal transduction involved in mitotic G2/M transition DNA damage checkpoint


name: signal transduction by cis-phosphorylation


name: signal transduction by conformational transition


name: signal transduction by protein phosphorylation


name: signal transduction by trans-phosphorylation


name: electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity


name: electron transporter, transferring electrons within cytochrome c oxidase complex activity


name: peptidase activity, acting on D-amino acid peptides


name: peptidase activity, acting on L-amino acid peptides


name: sodium-dependent L-ascorbate transmembrane transporter activity


name: 2-hydroxy-adenosine triphosphate pyrophosphatase activity


name: viral triggering of virus induced gene silencing


name: ATP-dependent chloride transmembrane transporter activity


name: ATPase-coupled chloride transmembrane transporter activity


name: ATP-dependent rhamnose transmembrane transporter activity


name: ATPase-coupled rhamnose transmembrane transporter activity


name: manganese transmembrane transporter activity, phosphorylative mechanism


name: alkylphosphonate transmembrane transporter activity


name: organic phosphonate transmembrane transporter activity


name: ATPase-coupled spermidine transmembrane transporter activity


name: ATP-dependent glycerol-2-phosphate transmembrane transporter activity


name: ATPase-coupled glycerol-2-phosphate transmembrane transporter activity


name: ATPase-coupled heme transporter activity


name: ATPase-coupled fatty-acyl-CoA transmembrane transporter activity


name: ATP-dependent iron-chelate transporter activity


name: ATPase-coupled iron-chelate transporter activity


name: oxidoreductase activity, reducing metal ions


name: oxidoreductase activity, reducing metal ions, NAD or NADP as acceptor


name: divalent inorganic cation transmembrane transporter activity


name: monovalent inorganic cation transmembrane transporter activity


name: trivalent inorganic cation transmembrane transporter activity


name: signal transduction involved in cell size control checkpoint


name: G1 cell size control checkpoint signalling


name: signal transduction involved in G1 cell size control checkpoint


name: signal transduction involved in mitotic cell cycle G1/S transition size control checkpoint


name: signal transduction involved in G2 cell size control checkpoint


name: signal transduction involved in G2/M transition size control checkpoint


name: signal transduction involved in mitotic cell cycle G2/M transition size control checkpoint


name: signal transduction involved in mitotic cell cycle G1/S transition DNA damage checkpoint


name: signal transduction involved in mitotic G1 DNA damage checkpoint


name: granulocyte macrophage colony-stimulating factor biosynthetic process


name: hepatocyte growth factor biosynthetic process


name: interleukin-1 alpha biosynthetic process


name: tumor necrosis factor biosynthetic process


name: regulation of chemokine biosynthetic process


name: regulation of connective tissue growth factor biosynthetic process


name: regulation of fractalkine biosynthetic process


name: regulation of granulocyte macrophage colony-stimulating factor biosynthetic process


name: regulation of hepatocyte growth factor biosynthetic process


name: regulation of interferon-alpha biosynthetic process


name: regulation of interferon-alpha secretion


name: regulation of interferon-beta biosynthetic process


name: regulation of interferon-gamma biosynthetic process


name: regulation of interleukin-1 alpha biosynthetic process


name: regulation of interleukin-1 alpha secretion


name: regulation of interleukin-1 beta biosynthetic process


name: regulation of interleukin-1 beta secretion


name: regulation of interleukin-1 biosynthetic process


name: regulation of interleukin-10 biosynthetic process


name: regulation of interleukin-11 biosynthetic process


name: regulation of interleukin-12 biosynthetic process


name: regulation of interleukin-13 biosynthetic process


name: regulation of interleukin-15 biosynthetic process


name: regulation of interleukin-16 biosynthetic process


name: regulation of interleukin-17 biosynthetic process


name: regulation of interleukin-18 biosynthetic process


name: regulation of interleukin-19 biosynthetic process


name: regulation of interleukin-2 biosynthetic process


name: regulation of interleukin-20 biosynthetic process


name: regulation of interleukin-21 biosynthetic process


name: regulation of interleukin-22 biosynthetic process


name: regulation of interleukin-23 biosynthesis


name: regulation of interleukin-23 biosynthetic process


name: regulation of interleukin-24 biosynthetic process


name: regulation of interleukin-25 biosynthetic process


name: regulation of interleukin-26 biosynthetic process


name: regulation of interleukin-27 biosynthetic process


name: regulation of interleukin-3 biosynthetic process


name: regulation of interleukin-4 biosynthetic process


name: regulation of interleukin-5 biosynthetic process


name: regulation of interleukin-6 biosynthetic process


name: regulation of interleukin-7 biosynthetic process


name: regulation of interleukin-8 biosynthetic process


name: regulation of interleukin-9 biosynthetic process


name: regulation of TRAIL biosynthetic process


name: regulation of tumor necrosis factor biosynthetic process


name: regulation of tumor necrosis factor secretion


name: regulation of lymphotoxin A biosynthetic process


name: negative regulation of chemokine biosynthetic process


name: negative regulation of chemokine secretion


name: negative regulation of connective tissue growth factor biosynthetic process


name: negative regulation of CX3CL1 biosynthesis


name: negative regulation of fractalkine biosynthetic process


name: negative regulation of granulocyte macrophage colony-stimulating factor biosynthetic process


name: negative regulation of hepatocyte growth factor biosynthetic process


name: negative regulation of interferon-alpha biosynthetic process


name: negative regulation of interferon-alpha secretion


name: negative regulation of interferon-beta biosynthetic process


name: negative regulation of interferon-beta secretion


name: negative regulation of interferon-gamma biosynthetic process


name: negative regulation of interferon-gamma secretion


name: negative regulation of interleukin-1 alpha biosynthetic process


name: negative regulation of interleukin-1 alpha secretion


name: negative regulation of interleukin-1 beta biosynthetic process


name: negative regulation of interleukin-1 beta secretion


name: negative regulation of interleukin-1 biosynthetic process


name: negative regulation of interleukin-1 secretion


name: negative regulation of interleukin-10 biosynthetic process


name: negative regulation of interleukin-10 secretion


name: negative regulation of interleukin-11 biosynthetic process


name: negative regulation of interleukin-11 secretion


name: negative regulation of interleukin-12 biosynthetic process


name: negative regulation of interleukin-12 secretion


name: negative regulation of interleukin-13 biosynthetic process


name: negative regulation of interleukin-13 secretion


name: negative regulation of interleukin-15 biosynthetic process


name: negative regulation of interleukin-16 biosynthetic process


name: negative regulation of CTLA-8 production


name: negative regulation of interleukin-17 biosynthetic process


name: negative regulation of interleukin-17 secretion


name: negative regulation of interleukin-18 biosynthetic process


name: negative regulation of interleukin-18 secretion


name: negative regulation of interleukin-19 biosynthetic process


name: negative regulation of interleukin-2 biosynthetic process


name: negative regulation of interleukin-2 secretion


name: negative regulation of interleukin-20 biosynthetic process


name: negative regulation of interleukin-21 biosynthetic process


name: negative regulation of interleukin-22 biosynthetic process


name: negative regulation of interleukin-23 biosynthetic process


name: negative regulation of interleukin-24 biosynthetic process


name: negative regulation of interleukin-25 biosynthetic process


name: negative regulation of interleukin-25 secretion


name: negative regulation of interleukin-26 biosynthetic process


name: negative regulation of interleukin-27 biosynthetic process


name: negative regulation of interleukin-3 biosynthetic process


name: negative regulation of interleukin-4 biosynthetic process


name: negative regulation of interleukin-4 secretion


name: negative regulation of interleukin-5 biosynthetic process


name: negative regulation of interleukin-5 secretion


name: negative regulation of interleukin-6 biosynthetic process


name: negative regulation of interleukin-6 secretion


name: negative regulation of interleukin-7 biosynthetic process


name: negative regulation of interleukin-7 secretion


name: negative regulation of interleukin-8 biosynthetic process


name: negative regulation of interleukin-8 secretion


name: negative regulation of interleukin-9 biosynthetic process


name: negative regulation of TRAIL biosynthetic process


name: negative regulation of tumor necrosis factor biosynthetic process


name: negative regulation of tumor necrosis factor secretion


name: negative regulation of lymphotoxin A biosynthetic process


name: positive regulation of chemokine biosynthetic process


name: positive regulation of chemokine secretion


name: positive regulation of connective tissue growth factor biosynthetic process


name: positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process


name: positive regulation of hepatocyte growth factor biosynthetic process


name: positive regulation of interferon-alpha biosynthetic process


name: positive regulation of interferon-alpha secretion


name: positive regulation of interferon-beta biosynthetic process


name: positive regulation of interferon-beta secretion


name: positive regulation of interferon-gamma biosynthetic process


name: positive regulation of interferon-gamma secretion


name: positive regulation of interleukin-1 alpha biosynthetic process


name: positive regulation of interleukin-1 alpha secretion


name: positive regulation of interleukin-1 beta biosynthetic process


name: positive regulation of interleukin-1 beta secretion


name: positive regulation of interleukin-1 biosynthetic process


name: positive regulation of interleukin-1 secretion


name: positive regulation of interleukin-10 biosynthetic process


name: positive regulation of interleukin-10 secretion


name: positive regulation of interleukin-11 biosynthetic process


name: positive regulation of interleukin-11 secretion


name: positive regulation of interleukin-12 biosynthetic process


name: positive regulation of interleukin-12 secretion


name: positive regulation of interleukin-13 biosynthetic process


name: positive regulation of interleukin-13 secretion


name: positive regulation of interleukin-15 biosynthetic process


name: positive regulation of interleukin-16 biosynthetic process


name: positive regulation of interleukin-17 biosynthetic process


name: positive regulation of interleukin-17 secretion


name: positive regulation of interleukin-18 biosynthetic process


name: positive regulation of interleukin-18 secretion


name: positive regulation of interleukin-19 biosynthetic process


name: positive regulation of interleukin-2 biosynthetic process


name: positive regulation of interleukin-2 secretion


name: positive regulation of interleukin-20 biosynthetic process


name: positive regulation of interleukin-21 biosynthetic process


name: positive regulation of interleukin-22 biosynthetic process


name: positive regulation of interleukin-23 biosynthetic process


name: positive regulation of interleukin-24 biosynthetic process


name: positive regulation of interleukin-25 biosynthetic process


name: positive regulation of interleukin-25 secretion


name: positive regulation of interleukin-26 biosynthetic process


name: positive regulation of interleukin-27 anabolism


name: positive regulation of interleukin-27 biosynthetic process


name: positive regulation of interleukin-3 biosynthetic process


name: positive regulation of interleukin-4 biosynthetic process


name: positive regulation of interleukin-4 secretion


name: positive regulation of interleukin-5 biosynthetic process


name: positive regulation of interleukin-5 secretion


name: positive regulation of interleukin-6 biosynthetic process


name: positive regulation of interleukin-6 secretion


name: positive regulation of interleukin-7 biosynthetic process


name: positive regulation of interleukin-7 secretion


name: positive regulation of interleukin-8 biosynthetic process


name: positive regulation of interleukin-8 secretion


name: positive regulation of interleukin-9 biosynthetic process


name: positive regulation of TRAIL biosynthetic process


name: positive regulation of cachectin secretion


name: positive regulation of tumor necrosis factor biosynthesis


name: positive regulation of tumor necrosis factor biosynthetic process


name: positive regulation of tumor necrosis factor formation


name: positive regulation of lymphotoxin A biosynthetic process


name: oligogalacturonide transmembrane transporter activity


name: 2-aminoethylphosphonate transmembrane transporter activity


name: 2-phosphonoethylamine transmembrane transporter activity


name: ATP-dependent methionine transmembrane transporter activity


name: ATPase-coupled methionine transmembrane transporter activity


name: D-methionine transmembrane transporter activity


name: methionine transmembrane-transporting ATPase activity


name: signal transduction involved in mitotic DNA replication checkpoint


name: signal transduction involved in mitotic G2/M transition decatenation checkpoint


name: enhancement by symbiont of host defense-related programmed cell death


name: chemokine (C-C motif) ligand 6 secretion


name: regulation of chemokine (C-C motif) ligand 6 secretion


name: negative regulation of chemokine (C-C motif) ligand 6 secretion


name: positive regulation of chemokine (C-C motif) ligand 6 secretion


name: ATPase activity, coupled to movement of substances


name: defense response to bacterium, incompatible interaction


name: resistance response to pathogenic bacteria


name: aryl-CoA synthetase (ADP-forming) activity


name: oxidoreductase activity, reducing metal ions, flavin as acceptor


name: development of symbiont during interaction with host


name: development of symbiont involved in interaction with host


name: multi-species biofilm formation in or on host organism


name: multi-species biofilm formation on inanimate substrate


name: multi-species submerged biofilm formation


name: glial cell line-derived neurotrophic factor production


name: intracellular signal transduction pathway involved in mitotic DNA damage checkpoint


name: intracellular signaling pathway involved in mitotic DNA damage checkpoint


name: intracellular signal transduction pathway involved in mitotic cell cycle G2/M transition decatenation checkpoint


name: intracellular signal transduction pathway involved in topo II checkpoint


name: intracellular signal transduction pathway involved in topoisomerase II checkpoint


name: intracellular signaling pathway involved in mitotic cell cycle G2/M transition decatenation checkpoint


name: intracellular signaling pathway involved in topo II checkpoint


name: intracellular signaling pathway involved in topoisomerase II checkpoint


name: signal transduction via intracellular signaling cascade involved in mitotic cell cycle G2/M transition decatenation checkpoint


name: signal transduction via intracellular signaling cascade involved in topo II checkpoint


name: defense response to fungus, incompatible interaction


name: modulation by organism of apoptotic process in other organism involved in symbiotic interaction


name: modulation of programmed cell death in other organism


name: modulation of programmed cell death in other organism involved in symbiotic interaction


name: activation by organism of apoptotic programmed cell death in other organism during symbiotic interaction


name: enhancement of other organism programmed cell death by organism


name: arrest of mitotic cell cycle progression


name: negative regulation of cell cycle arrest


name: positive regulation of cell cycle arrest


name: endoplasmic reticulum localisation involved in endoplasmic reticulum polarization at cell division site


name: ER localization involved in ER polarization at cell division site


name: establishment of endoplasmic reticulum localisation involved in endoplasmic reticulum polarization at cell division site


name: maintenance of endoplasmic reticulum location involved in endoplasmic reticulum polarization at cell division site


name: transitional endoplasmic reticulum polarization at cell division site


name: peptide-L-aspartate,2-oxoglutarate:oxygen oxidoreductase (3-hydroxylating) activity


name: regulation of interleukin-35 biosynthetic process


name: negative regulation of interleukin-35 biosynthetic process


name: positive regulation of interleukin-35 biosynthetic process


name: transforming growth factor-beta secretion


name: regulation of transforming growth factor-beta secretion


name: negative regulation of transforming growth factor-beta secretion


name: positive regulation of transforming growth factor-beta secretion


name: chaperone-mediated protein transport across periplasmic space


name: regulation of encysted zoospore germination on or near host


name: atrioventricular junction myocyte to bundle branch myocyte


name: bundle branch myocyte to Purkinje myocyte communication


name: bundle of His myocyte to atrioventricular junction myocyte


name: cell motility involved in somitogenic axis elongation


name: defence response incompatible interaction


name: defence response to pathogen, incompatible interaction


name: cytoskeletal protein membrane tether activity


name: regulation of UDP-GlcNAc biosynthetic process


name: regulation of UDP-N-acetylglucosamine anabolism


name: regulation of UDP-N-acetylglucosamine biosynthesis


name: regulation of UDP-N-acetylglucosamine formation


name: regulation of UDP-N-acetylglucosamine synthesis


name: negative regulation of UDP-GlcNAc biosynthesis


name: negative regulation of UDP-N-acetylglucosamine biosynthetic process


name: negative regulation of UDP-N-acetylglucosamine anabolism


name: negative regulation of UDP-N-acetylglucosamine biosynthesis


name: negative regulation of UDP-N-acetylglucosamine formation


name: negative regulation of UDP-N-acetylglucosamine synthesis


name: positive egulation of UDP-N-acetylglucosamine formation


name: positive regulation of UDP-GlcNAc biosynthetic process


name: positive regulation of UDP-N-acetylglucosamine anabolism


name: positive regulation of UDP-N-acetylglucosamine biosynthesis


name: positive regulation of UDP-N-acetylglucosamine synthesis


name: regulation of N-terminal signal peptide-independent translocation into the ER


name: regulation of SRP-independent endoplasmic reticulum protein-membrane targeting, translocation


name: negative regulation of N-terminal signal peptide-independent translocation into the ER


name: negative regulation of SRP-independent endoplasmic reticulum protein-membrane targeting, translocation


name: inhibition of heterochromatin organization


name: activation of heterochromatin organization


name: stimulation of heterochromatin organization


name: inhibition of chromosome attachment to the nuclear envelope


name: activation of chromosome attachment to the nuclear envelope


name: stimulation of chromosome attachment to the nuclear envelope


name: activation of cerebral blood circulation


name: inhibition of cerebral blood circulation


name: correction of merotelic kinetochore attachment, mitotic


name: correction of syntelic kinetochore attachment, mitotic


name: repair of mitotic merotelic kinetochore attachment defects


name: repair of mitotic mono-orientation defects


name: regulation of eIF2 alpha phosphorylation by amino acid starvation


name: positive regulation of transmigration of symbiont in host


name: ATPase-coupled iron-sulfur cluster transmembrane transporter activity


name: regulation of endoplasmic reticulum degradation


name: granzyme-mediated cell death signaling pathway


name: transmembrane helix dislocasentransmembrane protein dislocase activity


name: iodide peroxidase-tyrosine iodinase activity


name: regulation of interleukin-33 biosynthetic process


name: negative regulation of interleukin-33 biosynthetic process


name: negative regulation of interleukin-33 secretion


name: positive regulation of interleukin-33 biosynthetic process


name: positive regulation of interleukin-33 secretion


name: regulation of interleukin-34 biosynthetic process


name: positive regulation of interleukin-34 biosynthetic process


name: negative regulation of interleukin-34 biosynthetic process


name: negative regulation of interleukin-32 secretion


name: positive regulation of interleukin-32 secretion


name: regulation of defense response to fungi, incompatible interaction


name: regulation of resistance response to pathogenic fungi


name: regulation of response to pathogenic fungus (incompatible interaction)


name: activation of resistance response to pathogenic bacteria


name: positive regulation of defense response to bacterium, incompatible interaction


name: sequestration of proteasome core complex in proteasome storage granule


name: modulation of spore germination on or near host


name: negative regulation of spore germination on or near host


name: correction of merotelic kinetochore attachment, meiosis I


name: repair of merotelic kinetochore attachment defect, meiosis I


name: microtubule sliding involved in mitotic metaphase chromosome recapture


name: chemokine (C-C motif) ligand 2 secretion


name: negative regulation of chemokine (C-C motif) ligand 2 secretion


name: positive regulation of chemokine (C-C motif) ligand 2 secretion


name: positive regulation of spore germination on or near host


name: G protein-coupled opioid receptor activity


name: regulation of synaptic assembly at neuromuscular junction


name: ABC-type putrescine transporter activity


name: oxidoreductase activity, acting on metal ions


name: oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor


name: oxidoreductase activity, acting on metal ions, oxygen as acceptor


name: mitotic cell size control checkpoint signaling


name: ABC-type D-methionine transporter activity


name: G protein-coupled enkephalin receptor activity


name: carbohydrate-exporting ABC transporter activity


name: P-type divalent copper transporter activity


name: oxidoreductase activity, acting on metal ions, flavin as acceptor


name: regulation of biological process involved in symbiotic interaction


name: formation of structure involved in a symbiotic process


name: modulation of formation of structure involved in a symbiotic process


name: negative regulation of formation of structure involved in a symbiotic process


name: positive regulation of formation of structure involved in a symbiotic process


name: biological process involved in symbiotic interaction


name: glial cell-derived neurotrophic factor production


name: ABC-type phytochelatin transporter activity


name: synaptic assembly at neuromuscular junction


name: biological process involved in interaction with symbiont


name: effector-mediated suppression of host pattern-triggered immunity


name: ergothioneine biosynthesis from histidine via gamma-glutamyl-hercynylcysteine sulfoxide


name: positive regulation of sporangium germination


name: negative regulation of sporangium germination


name: formation of arbuscule for nutrient acquisition


name: formation of stylet for nutrient acquisition


name: regulation of cell migration involved in somitogenic axis elongation


name: acyl-lipid omega-(9-4) desaturase activity


name: tRNA uridine(34) acetyltransferase activity


name: protein serine kinase activity (using GTP as donor)


name: 3,5-dichloro-THPH methyl transferase activity


name: D-arabinose 1-dehydrogenase (NADP+) activity


name: regulation of UDP-N-acetylglucosamine biosynthetic process


name: positive regulation of UDP-N-acetylglucosamine biosynthetic process


name: chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity


name: isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity


name: ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity


name: regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA


name: superoxide-generating NADH oxidase activity


name: arachidonic acid 5,6-epoxygenase activity


name: arachidonic acid 8,9-epoxygenase activity


name: methylenetetrahydrofolate reductase NADH activity


name: (R)-limonene 1,2-monooxygenase NADH activity


name: (R)-limonene 1,2-monooxygenase NADPH activity


name: S-(hydroxymethyl)glutathione dehydrogenase NADP activity


name: (S)-limonene 1,2-monooxygenase NADPH activity


name: (S)-limonene 1,2-monooxygenase NADH activity


name: tRNA (cytidine 32-2'-O)-methyltransferase activity


name: tRNA (guanosine 34-2'-O)-methyltransferase activity


name: 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate synthase activity from histidine and PLP


name: U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity


name: U2 snRNA adenosine m6 methytransferase activity


name: octaprenyl pyrophosphate synthase activity


name: 4-hydroxybenzoate 3-monooxygenase [NADH] activity


name: 4-hydroxybenzoate 3-monooxygenase [NADPH] activity


name: glycerol-1-phosphate dehydrogenase [NAD+] activity


name: glycerol-1-phosphate dehydrogenase [NADP+] activity


name: (deoxy)nucleoside phosphate kinase activity, dGTP as phosphate donor


name: (deoxy)nucleoside phosphate kinase activity, dTTP as phosphate donor


name: (deoxy)nucleoside phosphate kinase activity, GTP as phosphate donor


name: fluorescent chlorophyll catabolite monooxygenase (deformylase) activity


name: primary fluorescent dioxobilin-type chlorophyll catabolite methylesterase activity


name: deoxynucleoside triphosphate hydrolase activity


name: regulation of post-translational protein targeting to membrane, translocation


name: negative regulation of post-translational protein targeting to membrane, translocation


name: terminal acetylenic compound biosynthetic process


name: terminal acetylenic compound metabolic process


name: terminal acetylenic compound catabolic process


name: acetylenic compound biosynthetic process


name: regulation of heterochromatin organization


name: negative regulation of heterochromatin organization


name: positive regulation of heterochromatin organization


name: regulation of chromosome attachment to the nuclear envelope


name: negative regulation of chromosome attachment to the nuclear envelope


name: positive regulation of chromosome attachment to the nuclear envelope


name: regulation of cerebral blood circulation


name: positive regulation of cerebral blood circulation


name: negative regulation of cerebral blood circulation


name: stalled replication fork localization to nuclear periphery


name: negative regulation of mitotic recombination-dependent replication fork processing


name: cellular response to actin cytoskeletal stress


name: regulation of oocyte karyosome formation


name: negative regulation of oocyte karyosome formation


name: positive regulation of oocyte karyosome formation


name: suppression by symbiont of host cytokine production


name: transcription regulator inhibitor activity


name: silent mating-type cassette heterochromatin organization


name: iron-sulfur cluster export from the mitochondrion


name: positive regulation of transepithelial migration of symbiont in host


name: telomere-nuclear envelope anchor activity


name: mitochondrion-endoplasmic reticulum membrane tether activity


name: ergothioneine biosynthesis from histidine via hercynylcysteine sulfoxide synthase


name: mitotic spindle pole body insertion into the nuclear envelope


name: ABC-type iron-sulfur cluster transporter activity


name: 5-aminolevulinic acid import across plasma membrane


name: 5-aminolevulinic acid transmembrane transporter activity


name: very long-chain fatty acid beta-oxidation


name: negative regulation of mitotic spindle assembly checkpoint signaling


name: effector-mediated suppression of host salicylic acid-mediated innate immune signalling


name: endoplasmic reticulum-autophagosome adaptor activity


name: granzyme-mediated programmed cell death signaling pathway


name: mitotic nuclear pore complex disassembly


name: double membrane vesicle viral factory assembly


name: regulation of osmosensory signaling MAPK cascade


name: negative regulation of osmosensory signaling MAPK cascade


name: suppression of host RNAi-mediated antiviral immune response


name: transcription regulator activator activity


name: negative regulation of conjugation with zygote


name: regulation of melanotic encapsulation of foreign target


name: negative regulation melanotic encapsulation of foreign target


name: envenomation resulting in blood agglutination in another organism


name: EGF-domain serine glucosyltransferase activity


name: EGF-domain serine xylosyltransferase activity


name: extraction of mislocalized protein from membrane


name: extraction of mislocalized protein from ER membrane


name: extraction of mislocalized protein from mitochondrial outer membrane


name: transmembrane monodehydroascorbate reductase activity


name: mitochondrion autophagosome adaptor activity


name: P-type monovalent copper transporter activity


name: adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway


name: effector-mediated suppression of host defense response


name: xyloglucan-specific endo-beta-1,4-glucanase inhibitor activity


name: proton motive force-driven motor activity


name: cysteine-type endopeptidase activator activity


name: ferric-chelate reductase (NADH) activity


name: opioid growth factor receptor signaling pathway


name: ubiquitin-dependent protein catabolic process via the C-end degron rule pathway


name: outward rectifier potassium channel inhibitor activity


name: small conductance calcium-activated potassium channel inhibitor activity


name: aldehyde dehydrogenase (NAD+) inhibitor activity


name: negative regulation of interleukin-37 production


name: positive regulation of interleukin-37 production


name: regulation of interleukin-17A production


name: negative regulation of interleukin-17A production


name: positive regulation of interleukin-17A production


name: negative regulation of interleukin-32 production


name: positive regulation of interleukin-32 production


name: regulation of glial cell-derived neurotrophic factor production


name: positive regulation of glial cell-derived neurotrophic factor production


name: ABC-type doxorubicin transporter activity


name: iron-sulfur cluster transmembrane transport


name: positive regulation of small GTPase binding


name: S-(hydroxymethyl)glutathione dehydrogenase NAD activity


name: Nuclear Ab pattern.smooth nuclear envelope


name: Bed mobility - self-performance during assessment period


name: Bed mobility - support provided during assessment period


name: Transfer - self-performance during assessment period


name: Walk in room - self-performance during assessment period


name: Walk in room - support provided during assessment period


name: Walk in corridor - self-performance during assessment period


name: Walk in corridor - support provided during assessment period


name: Locomotion on unit - self-performance during assessment period


name: Locomotion on unit - support provided during assessment period


name: Locomotion off unit - self-performance during assessment period


name: Locomotion off unit - support provided during assessment period


name: Dressing - self-performance during assessment period


name: Dressing - support provided during assessment period


name: Eating - self-performance during assessment period


name: Eating - support provided during assessment period


name: Toilet use - self-performance during assessment period


name: Toilet use - support provided during assessment period


name: Personal hygiene - self-performance during assessment period


name: Personal hygiene - support provided during assessment period


name: Bathing - self-performance during assessment period


name: Bathing - support provided during assessment period


name: MDS v3.0 - RAI v1.16.1 - Staff assessment for mental status


name: MDS v3.0 - RAI v1.16.1 - Bladder and bowel - ND, SD


name: MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NC


name: MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NP, NQ, SP


name: Intervention or enabling service minutes


name: Association of Asian Pacific Community Health Organizations enabling services and social intervention panel


name: Mycobacterium tuberculosis stimulated gamma interferon release by T-cells


name: SARS coronavirus 2 variant interpretation


name: Accountable health communities health-related social needs screening tool


name: Tobacco, Alcohol, Prescription medications, and other Substance use assessment


name: Have you tried and failed to control, cut down or stop drinking in past 3Mo


name: Has anyone expressed concern about your drinking in past 3Mo


name: Have you had a strong desire or urge to use marijuana at least once a week or more often in past 3Mo


name: Has anyone expressed concern about your use of marijuana in past 3Mo


name: Has anyone expressed concern about your use of cocaine, crack, or methamphetamine in past 3Mo


name: Have you tried and failed to control, cut down or stop using heroin in past 3Mo


name: Has anyone expressed concern about your use of heroin in past 3Mo


name: Have you tried and failed to control, cut down or stop using an opiate pain reliever in past 3Mo


name: Has anyone expressed concern about your use of an opiate pain reliever in past 3Mo


name: Have you had a strong desire or urge to use medications for anxiety or sleep at least once a week or more often in past 3Mo


name: Has anyone expressed concern about your use of medication for anxiety or sleep in past 3Mo


name: Has anyone expressed concern about your use of a medication for ADHD in past 3Mo


name: SARS coronavirus 2 sequencing & identification panel


name: MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP


name: MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP


name: Acanthamoeba sp & Naegleria fowleri & Balamuthia mandrillaris DNA panel


name: Average diameter on axial mid-scan image


name: Noninvasive prenatal fetal aneuploidy & 22q11.2 deletion panel


name: Comment on overall fetal aneuploidy risk


name: Vaccine doses distributed/100,000 population


name: people who have received first dose of vaccine


name: People who have received first dose of vaccine/100,000 population


name: People who are fully vaccinated/100,000 population


name: People in long-term care facilities who have received first dose of vaccine


name: People in long-term care facilities who are fully vaccinated


name: Accountable health communities health-related social needs supplemental questions


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel


name: COVID-19 experiences - employment and school changes panel


name: Carbapenem resistant bacteria identification & resistance panel


name: Staphylococcus aureus identification & resistance panel


name: Core Outcome Measures Index for the Neck


name: How much did health condition interfere with normal work in past W


name: Glucose measurements in range/Total glucose measurements


name: Gastrointestinal dysmotility autoimmune Ab panel


name: Necrotizing myopathy autoimmune Ab panel


name: B-cell primary immunodeficiency multigene analysis


name: Myasthenia gravis & Lambert-Eaton syndrome autoimmune Ab panel


name: Glial fibrillary acidic protein & Ubiquitin carboxyl-terminal hydrolase-L1 panel


name: Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1


name: Hereditary breast & gynecologic cancer multigene analysis


name: Core Outcome Measures Index for the Back


name: Medium induced in vitro yeast conversion


name: Glomerular filtration rate/Body surface area


name: Natural killer cell cytotoxicity.IL-2 stimulated panel


name: Body weight.current fetus/Body weight.heaviest fetus


name: Jewish descent preconception &or prenatal carrier screening multigene analysis


name: CFTR gene & FMR1 gene CGG repeat & SMN1 gene mutation analysis


name: Preconception &or prenatal carrier screening multigene analysis


name: SARS coronavirus 2 variant:Type:Pt:XXX:Nom:Sequencing


name: SARS coronavirus 2 Ab.IgG:MCnc:Pt:Ser/Plas:Qn:IA


name: SARS coronavirus 2 S gene mutation detected:Prid:Pt:XXX:Nom:Molgen


name: SARS coronavirus 2 S gene mutation:PrThr:Pt:XXX:Ord:Molgen


name: Mycobacterium tuberculosis stimulated gamma interferon release by T-cells^^corrected for background:ACnc:Pt:Bld:Qn


name: SARS coronavirus 2 variant interpretation:Imp:Pt:XXX:Nar


name: SARS coronavirus 2 S gene codon N501=:PrThr:Pt:XXX:Ord:Molgen


name: SARS coronavirus 2 S gene codon N501Y:PrThr:Pt:XXX:Ord:Molgen


name: SARS coronavirus 2 E gene:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: SARS coronavirus 2 S gene:PrThr:Pt:Saliva:Ord:Probe.amp.tar


name: (Fagus grandifolia+Pinus strobus+Thuja plicata+Abies alba) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Quercus alba+Swietenia+Thuja plicata+Triplochiton scleroxylon) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: SARS coronavirus 2 RNA:PrThr:Pt:Oropharyngeal wash:Ord:Probe.amp.tar


name: Glucose^30M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1H post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1H post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1.5H post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Eruca vesicaria subspecies sativa Ab.IgE:ACnc:Pt:Ser:Qn


name: SARS coronavirus 2 RNA:PrThr:Pt:XXX^Donor:Ord:Probe.amp.tar


name: SARS coronavirus 2 sequencing & identification panel:-:Pt:XXX:-:Molgen


name: SARS coronavirus 2 lineage:Prid:Pt:XXX:Nom:Molgen


name: SARS coronavirus 2 clade:Type:Pt:XXX:Nom:Molgen


name: SARS coronavirus 2 RNA panel:-:Pt:Oropharyngeal wash:-:Probe.amp.tar


name: SARS coronavirus 2 N gene:ThreshNum:Pt:Oropharyngeal wash:Qn:Probe.amp.tar


name: SARS coronavirus 2 ORF1ab region:ThreshNum:Pt:Oropharyngeal wash:Qn:Probe.amp.tar


name: SARS coronavirus 2 S gene:ThreshNum:Pt:Oropharyngeal wash:Qn:Probe.amp.tar


name: Acanthamoeba sp & Naegleria fowleri & Balamuthia mandrillaris DNA panel:-:Pt:XXX:-


name: Nuclear Ab pattern.spindle fibers:Titr:Pt:CSF:SemiQn:IF


name: Nuclear Ab pattern.smooth nuclear envelope:Titr:Pt:CSF:SemiQn:IF


name: Nuclear Ab pattern.intercellular bridge:Titr:Pt:CSF:SemiQn:IF


name: Nuclear Ab pattern.nuclear dots:Titr:Pt:CSF:SemiQn:IF


name: SARS coronavirus 2 M gene:PrThr:Pt:Respiratory.upper:Ord:Probe.amp.tar


name: SARS coronavirus 2 N gene:PrThr:Pt:Saliva:Ord:Probe.amp.tar.CDC primer-probe set N2


name: Varicella zoster virus Ab.IgM Index:ACnc:Pt:Ser+CSF:Qn


name: Varicella zoster virus Ab.IgG Index:ACnc:Pt:Ser+CSF:Qn


name: Bordetella pertussis.pertussis toxin promoter region:PrThr:Pt:Respiratory.lower:Ord:Probe.amp.tar


name: Grimontia holisae & Vibrio fluvialis & Vibrio harveyi DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: EZH2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CARD11 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CD79A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CD79B gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TNFAIP3 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: MYD88 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Noninvasive prenatal fetal aneuploidy panel:-:Pt:WBC.DNA+Plas.cfDNA:-:Dosage of chromosome specific cf DNA


name: Noninvasive prenatal fetal aneuploidy & 22q11.2 deletion panel:-:Pt:WBC.DNA+Plas.cfDNA:-:Dosage of chromosome specific cf DNA


name: Fetal trisomy 13+trisomy 18+triploidy risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Calculated


name: Comment on overall fetal aneuploidy risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal trisomy 13+trisomy 18+triploidy risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Calculated


name: SARS coronavirus 2 N gene:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: Maximum clot strength amplitude.kaolin+tissue factor induced:Len:Pt:Bld:Qn:Thromboelastography.resonance


name: Maximum clot strength amplitude.kaolin+tissue factor induced:Len:Pt:Bld:Qn


name: Clot initiation.kaolin induced^post heparin neutralization:Time:Pt:Bld:Qn:Thromboelastography.resonance


name: Clot initiation.kaolin+tissue factor induced:Time:Pt:Bld:Qn


name: Activated clotting time.kaolin+tissue factor induced:Time:Pt:Bld:Qn:Calculated


name: Clot formation.kaolin+tissue factor induced:Time:Pt:Bld:Qn


name: Clot angle.kaolin+tissue factor induced:Angle:Pt:Bld:Qn


name: Reduction in clot strength.kaolin+tissue factor induced^30M post maximum clot amplitude:LenFr:Pt:Bld:Qn


name: Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited:Len:Pt:Bld:Qn:Thromboelastography.resonance


name: Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited:Len:Pt:Bld:Qn


name: Maximum clot strength amplitude.kaolin induced^after addition of heparinase:Len:Pt:Bld:Qn


name: Maximum clot strength amplitude.activator F induced:Len:Pt:Bld:Qn


name: Maximum clot strength amplitude.adenosine diphosphate induced:Len:Pt:Bld:Qn


name: Maximum clot strength amplitude.arachidonate induced:Len:Pt:Bld:Qn


name: Reduction in clot strength.kaolin induced^30M post maximum clot amplitude:LenFr:Pt:Bld:Qn


name: Chemokine (C-C motif) ligand 2:MCnc:Pt:Ser/Plas:Qn


name: Granulocyte macrophage colony stimulating factor:MCnc:Pt:Ser/Plas:Qn


name: SARS coronavirus 2 Ag:PrThr:Pt:Respiratory.upper:Ord:IA.rapid


name: SARS coronavirus 2 Nsp2 gene:PrThr:Pt:Respiratory.upper:Ord:Probe.amp.tar


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel:-:Pt:Respiratory.upper:-:IA.rapid


name: Tau protein.phosphorylated 181/Amyloid beta 42 peptide:Ratio:Pt:CSF:Qn


name: SARS coronavirus 2 ORF1ab region:ACnc:Pt:Respiratory.upper:Qn:Probe.amp.tar


name: Chemokine (C-C motif) ligand 2:MCnc:Pt:Urine:Qn:IA


name: Hepatitis A virus cellular receptor 1:MCnc:Pt:Urine:Qn:IA


name: Fibroblast growth factor 19:MCnc:Pt:Ser/Plas:Qn:IA


name: Pro prostate specific Ag isoform 2:MCnc:Pt:Ser/Plas:Qn:IA


name: Hepatitis B virus core+little e+p22cr Ag:ACnc:Pt:Ser/Plas:Qn:IA


name: Human papilloma virus 6+11+42+43+44 DNA:PrThr:Pt:Genital:Ord:Probe.amp.sig


name: Cytokeratin 8 Ag:PrThr:Pt:Tissue:Ord:Immune stain


name: Yersinia outer protein Ab panel:-:Pt:Ser:-:Line blot


name: Yersinia outer protein M Ab:PrThr:Pt:Ser:Ord:Line blot


name: Yersinia LcrV protein Ab:PrThr:Pt:Ser:Ord:Line blot


name: Yersinia outer protein D Ab:PrThr:Pt:Ser:Ord:Line blot


name: Yersinia outer protein N Ab:PrThr:Pt:Ser:Ord:Line blot


name: Yersinia outer protein P Ab:PrThr:Pt:Ser:Ord:Line blot


name: Yersinia outer protein E Ab:PrThr:Pt:Ser:Ord:Line blot


name: Yersinia outer protein Ab band pattern:Imp:Pt:Ser:Nom:Line blot


name: West Nile virus RNA:PrThr:Pt:Urine:Ord:Probe.amp.tar


name: Bordetella parapertussis IS1001 DNA:PrThr:Pt:Respiratory.lower:Ord:Non-probe.amp.tar


name: Purkinje cell cytoplasmic type Tr Ab:PrThr:Pt:Ser:Ord


name: Escherichia coli enteroaggregative DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Escherichia coli enteropathogenic DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Escherichia coli enterotoxigenic DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Escherichia coli O157 DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Carbapenem resistant bacteria identification & resistance panel:-:Pt:Isolate/Specimen:-:Molgen


name: Staphylococcus aureus VNTR pattern:Type:Pt:Isolate/Specimen:Nom:Molgen


name: Staphylococcus aureus identification & resistance panel:-:Pt:Isolate/Specimen:-:Molgen


name: Prion disease biomarker panel:-:Pt:CSF:-


name: Glucose standard deviation:MCnc:RptPeriod:Interstitial fluid:Qn:Calculated


name: Glucose measurements in range/Total glucose measurements:NFr:RptPeriod:Interstitial fluid:Qn:Calculated


name: Fungal Ab panel:-:Pt:XXX:-:Immune diffusion


name: Campylobacter sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: Paracoccidioides sp Ab band pattern:Prid:Pt:XXX:Nom:Immune diffusion


name: Blastomyces sp Ab band pattern:Prid:Pt:XXX:Nom:Immune diffusion


name: Histoplasma capsulatum mycelial phase Ab band pattern:Prid:Pt:XXX:Nom:Immune diffusion


name: Coccidioides sp Ab band pattern:Prid:Pt:XXX:Nom:Immune diffusion


name: Hepatitis A virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Norovirus genogroup I RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Naegleria fowleri:PrThr:Pt:XXX:Ord:Organism specific culture


name: Norovirus genogroup II RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Somatotropin^3H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldCV:SemiQn


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldCV:Qn


name: Oxygen^^adjusted to patient's actual temperature:PPres:Pt:BldCV:Qn


name: Gastrointestinal dysmotility autoimmune Ab panel:-:Pt:Ser:-


name: Acetylcholine receptor binding Ab.IgG+IgM:SCnc:Pt:Ser:Qn:IA


name: Acetylcholine receptor ganglionic neuronal Ab.IgG+IgM:SCnc:Pt:Ser:Qn:IA


name: Voltage-gated potassium channel Ab.IgG+IgM:SCnc:Pt:Ser:Qn:IA


name: Necrotizing myopathy autoimmune Ab panel:-:Pt:Ser:-


name: Signal recognition particle Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Signal recognition particle Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: B-cell primary immunodeficiency multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Myasthenia gravis & Lambert-Eaton syndrome autoimmune Ab panel:-:Pt:Ser:-


name: Lymphocyte T-cell & B-cell & Natural killer subsets panel:-:Pt:Respiratory.lower:Qn:Flow cytometry


name: Microorganism of interest sequence:PrThr:Pt:XXX:Ord:Sequencing


name: Glial fibrillary acidic protein & Ubiquitin carboxyl-terminal hydrolase-L1 panel:-:Pt:Plas:-


name: Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1:Imp:Pt:Plas:Ord


name: Glial fibrillary acidic protein:MCnc:Pt:Plas:Qn:IA


name: Joint pathogens panel:-:Pt:Synv fld:-:Non-probe.amp.tar


name: Anaerococcus prevotii+vaginalis DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Bacteroides fragilis DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Candida albicans DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Candida sp DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Citrobacter sp DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Cutibacterium avidum+granulosum DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Enterobacter cloacae complex DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Enterococcus faecalis DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Enterococcus faecium DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Escherichia coli DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Finegoldia magna DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Haemophilus influenzae DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Kingella kingae DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Klebsiella aerogenes DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Morganella morganii DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Neisseria gonorrhoeae DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Peptoniphilus sp DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Peptostreptococcus anaerobius DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Proteus sp DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Pseudomonas aeruginosa DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Salmonella sp DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Serratia marcescens DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Staphylococcus aureus DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Staphylococcus lugdunensis DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Streptococcus agalactiae DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Streptococcus pneumoniae DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Streptococcus pyogenes DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Streptococcus sp DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^post DOAC neutralization^normalized:Ratio:Pt:PPP:Qn:Coag


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^^normalized:Ratio:Pt:PPP:Qn:Coag


name: Barmah forest virus Ab.IgG:PrThr:Pt:CSF:Ord:IA


name: Barmah forest virus Ab.IgM:PrThr:Pt:CSF:Ord:IA


name: SMN2 gene copy number:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: Hereditary breast & gynecologic cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine:MRto:Pt:Urine:Qn


name: Influenza virus types A & B & subtypes RNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Herpes virus 6 DNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar


name: Fungus & Mycobacterium sp identified:Prid:Pt:Bld:Nom:Organism specific culture


name: MLH1 gene methylation analysis:Find:Pt:Bld:Doc:Molgen


name: MLH1 gene methylation analysis:Find:Pt:Tumor:Doc:Molgen


name: Cortisol^post dose dexamethasone PO overnight:SCnc:Pt:Ser/Plas:Qn


name: Paracoccidioides sp Ab:Titr:Pt:XXX:SemiQn:Comp fix


name: Blastomyces sp Ab:Titr:Pt:XXX:SemiQn:Comp fix


name: Histoplasma capsulatum yeast phase Ab:Titr:Pt:XXX:SemiQn:Comp fix


name: Histoplasma capsulatum mycelial phase Ab:Titr:Pt:XXX:SemiQn:Comp fix


name: Coccidioides sp Ab:Titr:Pt:XXX:SemiQn:Comp fix


name: Herpes virus 8 Ab.IgM:PrThr:Pt:Ser/Plas:Ord:IF


name: Herpes virus 8 Ab.IgM:PrThr:Pt:Ser/Plas:Ord


name: Endogenous thrombin potential^after addition of Factor VIII Ab:TmSCnc:Pt:PPP:Qn:Chromo


name: Thrombin peak^after addition of Factor VIII Ab:Sub:Pt:PPP:Qn:Chromo


name: Time to thrombin peak:Time:Pt:PPP:Qn:Chromo


name: Thrombin generation test panel:-:Pt:PPP:-


name: Rift valley fever virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Tick-borne encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: California encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Sandfly fever Naples virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Jamestown canyon virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Snowshoe hare virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Highlands J virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Ross River virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Colorado tick fever virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Sandfly fever Sicilian virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Medium induced in vitro yeast conversion:Prid:Pt:Isolate:Nom:Culture


name: Cryptococcus sp:PrThr:Pt:Isolate:Ord:Organism specific culture


name: Color.fungal colony^with Chromogenic agar:Type:Pt:Isolate:Nom:Culture


name: Semliki Forest virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Venezuelan equine encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: GFR/Body surface area CKD-EPI [Vol rate/Area]


name: Rhinovirus+Enterovirus A+B+C RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Betula verrucosa recombinant (rBet v) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Olea europaea native (nOle e) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Dermatophagoides pteronyssinus recombinant (rDer p) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Dermatophagoides pteronyssinus recombinant (rDer p) 2 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Arachis hypogaea recombinant (rAra h) 8 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Arachis hypogaea recombinant (rAra h) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Arachis hypogaea recombinant (rAra h) 2 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Arachis hypogaea recombinant (rAra h) 3 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Gadus morhua recombinant (rGad c) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Arachis hypogaea recombinant (rAra h) 9 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Malus domestica recombinant (rMal d) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Malus domestica recombinant (rMal d) 3 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Corylus avellana recombinant (rCor a) 14 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Corylus avellana recombinant (rCor a) 9 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Phleum pratense recombinant (rPhl p) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Phleum pratense recombinant (rPhl p) 1+5b Ab.IgG4:MCnc:Pt:Ser:Qn


name: Vespula vulgaris recombinant (rVes v) 5 Ab.IgG4:MCnc:Pt:Ser:Qn


name: Apis mellifera recombinant (rApi m) 10 Ab.IgG4:MCnc:Pt:Ser:Qn


name: von Willebrand factor cleaving protease actual/normal:RelCCnc:Pt:PPP:Qn:IA


name: Herpes virus 6 Ab.IgM:PrThr:Pt:Ser:Ord:IF


name: Epstein Barr virus early Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: HLA-DP & DQ & DR (class II) Ab.IgG donor specific:Prid:Pt:Ser/Plas:Nom


name: HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II):Type:Pt:Bld/Tiss:Nom:High resolution


name: HLA-DP & DQ & DR (class II):Type:Pt:Bld/Tiss:Nom:Low resolution


name: HLA-A & B & C (class I):Type:Pt:Bld/Tiss:Nom:Low resolution


name: HLA-A & B & C (class I) Ab.IgG donor specific:Prid:Pt:Ser/Plas:Nom


name: HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II):Type:Pt:Bld/Tiss:Nom:Low resolution


name: B cell+T cell crossmatch:Imp:Pt:Ser+Bld:Nar


name: Plasma cell proliferation analysis:Find:Pt:Bone mar:Doc:FISH


name: Triiodothyronine^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Megakaryoblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Promegakaryocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Natural killer cell cytotoxicity.IL-2 stimulated panel:-:Pt:Bld MC:-:Flow cytometry


name: Jewish descent preconception &or prenatal carrier screening multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CFTR gene & FMR1 gene CGG repeat & SMN1 gene mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Linum usitatissimum seed Ab.IgE:ACnc:Pt:Ser:Qn


name: Bacterial beta-lactam resistance ESBL blaCTX-M-15 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance ESBL blaCTX-M-14 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-143 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial colistin resistance mcr-3+mcr-4+mcr-5 genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Barmah forest virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Color.yeast colony^with canavanine glycine+bromothymol blue:Type:Pt:Isolate:Nom:Culture


name: Apis mellifera phospholipase A2 recombinant (rApi m) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II) Ab:Prid:Pt:Ser/Plas:Nom


name: Preconception &or prenatal carrier screening multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SARS coronavirus 2 E gene:ThreshNum:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: PCNA extractable nuclear Ab:Titr:Pt:CSF:SemiQn:IF


name: Reduction in clot strength.kaolin induced^30M post maximum clot amplitude:LenFr:Pt:Bld:Qn:Thromboelastography.resonance


name: Acinetobacter calcoaceticus-baumannii complex DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA:PrThr:Pt:Genital:Ord:Probe.amp.sig


name: Yersinia outer protein H Ab:PrThr:Pt:Ser:Ord:Line blot


name: Parvimonas micra DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Parainfluenza virus 1+2+3+4 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) Ab.IgG:MCnc:Pt:Ser:Qn:Multidisk


name: Counselor/Therapist (certified or licensed)


name: Health Education - Large Group (13 or more)


name: Public health provider - public health clinic


name: Long-term care - nursing home, skilled nursing facility, federally certified


name: Public health provider - Federally Qualified Health Center


name: Public health provider - Rural Health Clinic


name: Long-term care - nursing home, skilled nursing facility, non-federally certified


name: Long-term care - intellectual or developmental disability


name: Other family members (e.g., aunt, uncle, cousin)


name: Vertebral body replacement by auto-/allograft


name: Would like help finding daycare for child:Find:Pt:^Caregiver:Ord


name: Always has enough food for family:Find:Pt:^Caregiver:Ord


name: At risk of having utilities shut off in the next week:Find:Pt:^Caregiver:Ord


name: Trouble paying heating bill &or electricity bill:Find:Pt:^Caregiver:Ord


name: Needs help getting food for family for tonight:Find:Pt:^Caregiver:Ord


name: Would like help getting food for family:Find:Pt:^Caregiver:Ord


name: Emergent risk of becoming homeless:Find:Pt:^Caregiver:Ord


name: Would like help for being at risk of becoming homeless:Find:Pt:^Caregiver:Ord


name: At risk of becoming homeless:Find:Pt:^Caregiver:Ord


name: Needs daycare for child:Find:Pt:^Caregiver:Ord


name: Would like help finding employment &or job training:Find:Pt:^Caregiver:Ord


name: Would like help to get a GED:Find:Pt:^Caregiver:Ord


name: WE CARE Survey:-:Pt:^Caregiver:-:WE CARE


name: LACE index score:Score:Pt:^Patient:Qn:LACE index


name: Intervention or enabling service minutes:Num:Pt:^Patient:Qn


name: Association of Asian Pacific Community Health Organizations enabling services and social intervention panel:-:Pt:^Patient:-:AAPCHO


name: Would like help with paying heating &or electricity bill:Find:Pt:^Caregiver:Ord


name: Service integration total score:Score:Pt:^Patient:Qn:R-Outcomes


name: Accountable health communities health-related social needs screening tool:-:Pt:^Patient:-


name: Coronavirus racial bias scale:-:Pt:^Patient:-:CRBS


name: Due to the coronavirus I have been cyberbullied because of my race or ethnicity:Find:Pt:^Patient:Ord:CRBS


name: Since the coronavirus I have seen a lot more cyberbullying of people of my race or ethnicity:Find:Pt:^Patient:Ord:CRBS


name: Tobacco, Alcohol, Prescription medications, and other Substance use screen:-:12Mo:^Patient:-:TAPS


name: How often have you used any prescription medications just for the feeling, more than prescribed or that were not prescribed for you in past 12Mo:NRat:12Mo:^Patient:Ord:TAPS


name: Tobacco, Alcohol, Prescription medications, and other Substance use assessment:-:3Mo:^Patient:-:TAPS


name: Have you tried and failed to control, cut down or stop drinking in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your drinking in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you had a strong desire or urge to use marijuana at least once a week or more often in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of marijuana in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of cocaine, crack, or methamphetamine in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you tried and failed to control, cut down or stop using heroin in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of heroin in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you tried and failed to control, cut down or stop using an opiate pain reliever in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of an opiate pain reliever in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you had a strong desire or urge to use medications for anxiety or sleep at least once a week or more often in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of medication for anxiety or sleep in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of a medication for ADHD in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Used other illegal or recreational drug in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: I believe the country has become more dangerous for people in my racial or ethnic group because of fear of the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: People of my race or ethnicity are more likely to lose their job because of the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: I worry about people thinking I have the coronavirus simply because of my race or ethnicity:Find:Pt:^Patient:Ord:CRBS


name: Most social and mass media reports about the coronavirus create bias against people of my racial or ethnic group:Find:Pt:^Patient:Ord:CRBS


name: People of my race or ethnicity are more likely to get the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: People of my race or ethnicity will not receive coronavirus healthcare as good as the care received by other groups:Find:Pt:^Patient:Ord:CRBS


name: Negative social media posts against people of my race or ethnicity have increased because of the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: MDS v3.0 - RAI v1.17.2 - Delirium:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status:-:RptPeriod:^Patient:-:CMS Assessment


name: Average diameter on axial mid-scan image:Len:Pt:^Patient:Qn:CT


name: Average diameter on frontal scout image:Len:Pt:^Patient:Qn:CT


name: Social determinants of health panel:-:Pt:^Patient:-:R-Outcomes


name: Social determinants of health score:Score:Pt:^Patient:Qn:R-Outcomes


name: Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise:PPresDiff:Pt:Exhl gas:Qn


name: Test result delivery method:Type:Pt:Referral lab test:Nom


name: Vaccine doses distributed/100,000 population:NRto:Pt:^Event:Qn


name: People who have received first dose of vaccine:Num:Pt:^Population:Qn


name: People who have received first dose of vaccine/100,000 population:NFr:Pt:^Population:Qn


name: People who are fully vaccinated:Num:Pt:^Population:Qn


name: People who are fully vaccinated/100,000 population:NFr:Pt:^Population:Qn


name: Vaccine doses distributed for use in long term care facilities:Num:Pt:^Event:Qn


name: People in long-term care facilities who have received first dose of vaccine:Num:Pt:^Population:Qn


name: People in long-term care facilities who are fully vaccinated:Num:Pt:^Population:Qn


name: Accountable health communities health-related social needs supplemental questions:-:Pt:^Patient:-


name: Spine Tango surgery follow-up 2017:-:Pt:^Patient:-:Spine Tango


name: Finnish diabetes risk score panel:-:Pt:^Patient:-:FINDRISC


name: Chronic diseases &or immunodeficiency:Hx:Pt:^Patient:Ord


name: Coagulation disorder &or blood-thinning medication use:Hx:Pt:^Patient:Ord


name: COVID-19 experiences - media use panel:-:Pt:^Patient:-:COVEX


name: Colonoscopy and endoscopic ultrasound study:Find:Pt:Lower GI tract:Doc:Colonoscopy+US


name: Flexible sigmoidoscopy and endoscopic ultrasound study:Find:Pt:Lower GI tract:Doc:Flexible sigmoidoscopy+US


name: Person who lost job or income due to COVID-19 outbreak:Find:Pt:^Household member:Nom


name: COVID-19 experiences - employment and school changes panel:-:Pt:^Patient:-:COVEX


name: COVID-19 experiences - coping panel:-:Pt:^Patient:-:COVEX


name: Core Outcome Measures Index for the Neck:-:Pt:^Patient:-:COMI


name: How much did health condition interfere with normal work in past W:Find:1W:^Patient:Ord


name: View AP external rotation:Find:Pt:Upper extremity.right>Shoulder:Doc:XR


name: View AP internal rotation:Find:Pt:Upper extremity.right>Shoulder:Doc:XR


name: View AP external rotation:Find:Pt:Upper extremity>Shoulder:Doc:XR


name: View AP internal rotation:Find:Pt:Upper extremity>Shoulder:Doc:XR


name: Views AP + oblique:Find:Pt:Chest>Clavicle.bilateral:Doc:XR


name: View AP external rotation:Find:Pt:Upper extremity.left>Shoulder:Doc:XR


name: View AP internal rotation:Find:Pt:Upper extremity.left>Shoulder:Doc:XR


name: Views lateral^W manual stress:Find:Pt:Upper extremity.bilateral>Elbow:Doc:XR


name: Views lateral^W manual stress:Find:Pt:Upper extremity.left>Elbow:Doc:XR


name: Views lateral^W manual stress:Find:Pt:Upper extremity.right>Elbow:Doc:XR


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen+Pelvis:Doc:MR


name: Guidance for injection:Find:Pt:Upper extremity.left>Elbow:Doc:US


name: Guidance for injection:Find:Pt:Upper extremity.right>Elbow:Doc:US


name: Guidance for injection:Find:Pt:Upper extremity.bilateral>Elbow:Doc:US


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.third:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.second:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.fifth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.fifth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.second:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.third:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.fifth:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.fourth:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.third:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.second:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.third:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.second:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.fifth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.third:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.second:Doc:XR


name: View AP:Find:Pt:Lower extremity.bilateral>Great toe:Doc:XR


name: View oblique:Find:Pt:Lower extremity.bilateral>Great toe:Doc:XR


name: View lateral:Find:Pt:Lower extremity.bilateral>Great toe:Doc:XR


name: view oblique:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: View lateral:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: View AP:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: View AP:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: View lateral:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: View oblique:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.fifth:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.third:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.second:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.fifth:Doc:XR


name: Progress note:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease


name: Progress note:Find:Pt:{Setting}:Doc:Colon and rectal surgery


name: Progress note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Progress note:Find:Pt:{Setting}:Doc:Heart failure+Transplant cardiology


name: Predicted response to cancer treatment:Find:Pt:^Patient:Ord:Based on lab data


name: Admission history and physical note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Evaluation note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Discharge instructions:Find:Pt:Emergency department:Doc:Emergency medicine


name: Discharge summary note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Discharge teaching note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Education note:Find:Pt:Emergency department:Doc:Emergency medicine


name: History and physical note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Initial evaluation note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Procedure note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Progress note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Transfer summary note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Triage note:Find:Pt:Emergency department:Doc:Emergency medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Interventional cardiology


name: History and physical note:Find:Pt:{Setting}:Doc:Interventional radiology


name: History and physical note:Find:Pt:{Setting}:Doc:Pulmonary disease


name: History and physical note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Anesthesiology


name: History and physical note:Find:Pt:{Setting}:Doc:Burn management


name: History and physical note:Find:Pt:{Setting}:Doc:Colon and rectal surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Nutrition and dietetics


name: History and physical note:Find:Pt:{Setting}:Doc:Infectious disease


name: History and physical note:Find:Pt:{Setting}:Doc:Nurse


name: History and physical note:Find:Pt:{Setting}:Doc:Pharmacology


name: History and physical note:Find:Pt:{Setting}:Doc:Radiation oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Radiology


name: History and physical note:Find:Pt:{Setting}:Doc:Rheumatology


name: History and physical note:Find:Pt:{Setting}:Doc:Trauma


name: Discharge summary note:Find:Pt:{Setting}:Doc:Interventional cardiology


name: Surgical operation note:Find:Pt:{Setting}:Doc:Interventional radiology


name: Evaluation note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Evaluation note:Find:Pt:{Setting}:Doc:Solid organ transplant


name: Discharge summary note:Find:Pt:{Setting}:Doc:Burn management


name: Discharge summary note:Find:Pt:{Setting}:Doc:Gynecologic oncology


name: Discharge summary note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery


name: Discharge summary note:Find:Pt:{Setting}:Doc:Radiation oncology


name: Surgical operation note:Find:Pt:{Setting}:Doc:Gynecologic oncology


name: Procedure note:Find:Pt:{Setting}:Doc:Solid organ transplant


name: Evaluation note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Discharge summary note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: History and physical note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Procedure note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Surgical operation note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: History and physical note:Find:Pt:{Setting}:Doc:Hepatology


name: History and physical note:Find:Pt:{Setting}:Doc:Hematology


name: Discharge summary note:Find:Pt:{Setting}:Doc:Sleep medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Sleep medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Occupational therapy


name: History and physical note:Find:Pt:{Setting}:Doc:Recreational therapy


name: History and physical note:Find:Pt:{Setting}:Doc:Respiratory therapy


name: Admission or pathology panel:-:Pt:^Patient:-:Spine Tango


name: Specification of main pathology panel:-:Pt:^Patient:-:Spine Tango


name: Surgical measures panel:-:Pt:^Patient:-:Spine Tango


name: Motion preserving spine stablization:Type:Pt:^Patient:Nom


name: Hospital stay panel:-:Pt:^Patient:-:Spine Tango


name: Stay Independent panel:-:Pt:^Patient:-:Stay Independent


name: Stay Independent total score:Score:Pt:^Patient:Qn:Stay Independent


name: Core Outcome Measures Index for the Neck score:Score:Pt:^Patient:Qn:COMI


name: Core Outcome Measures Index for the Back:-:Pt:^Patient:-:COMI


name: Core Outcome Measures Index for the Back score:Score:Pt:^Patient:Qn:COMI


name: Oswestry disability index score:Score:Pt:^Patient:Qn:ODI


name: Body weight.current fetus/Body weight.heaviest fetus:MRto:Pt:^Fetuses:Qn:US+Calculated


name: Multisection^W radionuclide IV:Find:Pt:Lower extremity:Doc:PT+CT


name: Views for therapy^W Tc-99m SC IV:Find:Pt:Abdomen:Doc:NM


name: Urothelial carcinoma recurrence score:Score:Pt:Urine:Qn:Molgen


name: XR|Elbow|Views lateral^W manual stress|Laterality:ANY


name: XR|Finger.fifth|Views AP + lateral|Laterality:ANY


name: XR|Finger.fourth|Views AP + lateral|Laterality:ANY


name: XR|Finger.second|Views AP + lateral|Laterality:ANY


name: XR|Finger.third|Views AP + lateral|Laterality:ANY


name: XR|Great toe|Views AP + lateral|Laterality:ANY


name: XR|Shoulder|View AP external rotation|Laterality:ANY


name: XR|Shoulder|View AP internal rotation|Laterality:ANY


name: XR|Toe.fifth|Views AP + lateral + oblique|Laterality:ANY


name: XR|Toe.fifth|Views AP + lateral|Laterality:ANY


name: XR|Toe.fourth|Views AP + lateral + oblique|Laterality:ANY


name: XR|Toe.fourth|Views AP + lateral|Laterality:ANY


name: XR|Toe.second|Views AP + lateral + oblique|Laterality:ANY


name: XR|Toe.second|Views AP + lateral|Laterality:ANY


name: XR|Toe.third|Views AP + lateral|Laterality:ANY


name: 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine|MRto|Urine


name: XR|Toe.third|Views AP + lateral + oblique|Laterality:ANY


name: at end expiration+W sub-maximal exercise


name: Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise


name: Total doses distributed per 100,000 population


name: Color.fungal colony^with Chromogenic agar


name: Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited^post heparin neutralization


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^^normalized


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^post DOAC neutralization^normalized


name: Blood flow velocity.max.stenosis.internal carotid artery


name: HIV ART actual prescription fills number


name: Intravascular systolic.posterior tibial artery


name: Volume at 25-75% of forced expiration.measured


name: Nucleic acid amplification using Centers for Disease Control and Prevention primer-probe set N3


name: Anaplasma marginale Ab/Negative control | Serum | Microbiology


name: Bordetella avium Ab/Positive control | Serum | Microbiology


name: Mycobacterium avium subspecies paratuberculosis Ab/Positive control | XXX | Microbiology


name: Mycobacterium tuberculosis stimulated gamma interferon release by T-cells | Blood | Microbiology


name: Mycoplasma gallisepticum Ab/Positive control | Serum | Microbiology


name: Mycoplasma hyorhinis Ab.IgG/Positive control | Serum | Microbiology


name: Mycoplasma synoviae Ab/Positive control | Serum | Microbiology


name: Salmonella choleraesuis+infantis+typhimurium Ab/Positive control | XXX | Microbiology


name: Yersinia outer protein Ab band pattern | Serum | Microbiology


name: Blastomyces sp Ab band pattern | XXX | Microbiology


name: Coccidioides sp Ab band pattern | XXX | Microbiology


name: Histoplasma capsulatum mycelial phase Ab band pattern | XXX | Microbiology


name: Paracoccidioides sp Ab band pattern | XXX | Microbiology


name: Neospora caninum Ab/Negative control | Serum | Microbiology


name: Avian encephalomyelitis virus Ab/Positive control | Serum | Microbiology


name: Avian paramyxovirus 1 Ab/Positive control | Serum | Microbiology


name: Avian metapneumovirus Ab/Positive control | Serum | Microbiology


name: Avian reovirus Ab/Positive control | Serum | Microbiology


name: Bluetongue virus Ag/Negative control | Serum | Microbiology


name: Bovine diarrhea virus Ag/Positive control | XXX | Microbiology


name: Infectious bronchitis virus Ab/Positive control | Serum | Microbiology


name: Infectious bursal disease virus Ab/positive control | Serum | Microbiology


name: West Nile virus Ab.IgM/Positive control | Serum | Microbiology


name: Anticomplementary activity | XXX | Microbiology


name: Color.fungal colony | Isolate | Microbiology


name: Color.mold colony | Isolate | Microbiology


name: Color.reverse pigment | Isolate | Microbiology


name: Color.yeast colony | Isolate | Microbiology


name: GISAID sequence accession number | Isolate | Microbiology


name: Medium induced in vitro yeast conversion | Isolate | Microbiology


name: Microorganism of interest sequence | XXX | Microbiology


name: Sequencing study identifier | Specimen | Microbiology


name: Texture.yeast colony | Isolate | Microbiology


name: Thermotolerance | Isolate | Microbiology


name: Acanthamoeba sp and Naegleria fowleri and Balamuthia mandrillaris DNA panel | XXX | Microbiology Panels


name: Chikungunya virus Ab.IgM and IgG panel | Serum or Plasma | Microbiology Panels


name: Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel | Anorectal | Microbiology Panels


name: Fungal Ab panel | XXX | Microbiology Panels